Skip to content
GLP-1 Scorecard
Menu

Evidence review

Compounded vs. Brand-Name GLP-1: What Actually Differs

Compare approval, formulation, evidence, costs, and continuity of care before discussing GLP-1 options with your clinician.

Published by GLP-1 Scorecard
On this page

Compounded and brand-name GLP-1 products differ in approval, formulation, evidence, and purchasing terms. The same ingredient name does not establish that two finished products are equivalent. This guide compares those decisions; the provider safety checklist addresses how to vet an operation.

Approval and evidence

An FDA-approved medicine has undergone the agency's review. A compounded preparation has not received that individual review and is not an FDA-approved generic.1 Evidence about an approved drug should not be presented as a trial of a pharmacy's specific preparation.

Brand names also matter within the approved category. Ozempic and Wegovy, and Mounjaro and Zepbound, have separate product labeling. Ask the prescriber which exact product and indication are being considered; a molecule name alone is incomplete.

Formulation and handling

A compounded preparation may have a different concentration, ingredients, or delivery format. FDA's concerns include semaglutide salt forms, dosing errors, and misleading unapproved-product claims.2 Do not assume the chemistry, absorption, or practical dosing instructions match an approved product.

For any prescribed product, ask for its exact name and instructions. The compounded vial-label guide explains the information to take to the dispensing pharmacist; the warm-shipment guide addresses delivery problems. A brand pen's storage allowance cannot simply be transferred to another formulation.

If you are choosing a seller, our yourEra review, our GoodLife Health review, and our PlexusDx review set out the prices, renewal terms and what we could not verify for each. All of these sellers pay us a commission when a reader signs up, which never changes a grade.

Why compounding is being considered

FDA describes compounding as a way to address needs that approved medicines cannot meet.1 Ask your clinician what need the proposed preparation addresses. Availability and price should be discussed, but they do not establish a product's equivalence or a particular preparation's regulatory status. See the shortage-rule explainer for that separate question.

Compare the full cost of the proposed care

Get two written estimates for the actual options your clinician considers appropriate. Include medication, recurring membership, appointments, labs, shipping, and any required prepayment. Mark each unknown rather than substituting a promotional starting price.

The six-month total-cost comparison shows this method across ten providers. Use the insurance guide to distinguish a benefit exclusion from a prior-authorization requirement. A cheap first month does not establish the cost of continuing care.

Plan for changes before starting

Ask who handles follow-up and what happens if the pharmacy, product, coverage, or price changes. Save cancellation deadlines separately from clinical instructions: stopping a subscription and changing treatment are different decisions. Our cancellation guide and switching-provider checklist cover those handoffs.

If a familiar name turns up on a different storefront, the AmberHealth profile shows why I’d verify the current program before assuming it offers prescriptions. The RxSpan MD review illustrates why I’d check the catalog against the homepage before treating an advertised price as a quote for a particular product. Bring the exact product, medical rationale, and total quote to the prescribing discussion. This comparison does not rank a compounded preparation as interchangeable with an approved medicine. Sources and wording were rechecked October 6, 2026; the earlier claim that only accountability, rather than chemistry, could differ has been removed.

Frequently asked questions

Is compounded semaglutide the same as a generic Wegovy?

No. A compounded preparation is not an FDA-approved generic and has not received an individual FDA approval.

Can I compare only the monthly medication price?

No. Include membership, visits, labs, shipping, prepayment, and the cost after introductory offers. Compare only treatment options your clinician considers appropriate.

References

  1. U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers. FDA.gov (accessed October 6, 2026). Read source
  2. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA.gov (accessed October 6, 2026). Read source

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.